The isolation, total synthesis and structure elucidation of chlorofusin, a natural product inhibitor of the p53-MDM2 protein-protein interaction

被引:36
|
作者
Clark, Ryan C. [2 ]
Lee, Sang Yeul [2 ]
Searcey, Mark [1 ]
Boger, Dale L. [2 ]
机构
[1] Univ E Anglia, Sch Chem Sci & Pharm, Norwich NR4 7TJ, Norfolk, England
[2] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
基金
美国国家卫生研究院;
关键词
CYCLIC PEPTIDE PORTION; SOLID-PHASE SYNTHESIS; ABSOLUTE-CONFIGURATION; P53/MDM2; INTERACTION; CANCER-THERAPY; MDM2; P53; AZAPHILONES; CHEMISTRY; FUNGI;
D O I
10.1039/b821676b
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inhibitors of key protein-protein interactions are emerging as exciting therapeutic targets for the treatment of cancer. One such interaction between MDM2 (HDM2) and p53, that silences the tumour suppression activities of p53, was found to be inhibited by the recently isolated natural product chlorofusin. Synthetic studies on this complex natural product summarized herein have served to reassign its chromophore relative stereochemistry, assign its absolute stereochemistry, and provided access to a series of key analogues and partial structures for biological evaluation.
引用
收藏
页码:465 / 477
页数:13
相关论文
共 50 条
  • [41] Flexibility is important for inhibition of the MDM2/p53 protein-protein interaction by cyclic β-hairpins
    Danelius, Emma
    Pettersson, Mariell
    Bred, Matilda
    Min, Jaeki
    Waddell, M. Brett
    Guy, R. Kiplin
    Grotli, Morten
    Erdelyi, Mate
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2016, 14 (44) : 10386 - 10393
  • [42] Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapy: Progress and Challenges
    Wang, Shaomeng
    Zhao, Yujun
    Aguilar, Angelo
    Bernard, Denzil
    Yang, Chao-Yie
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (05):
  • [43] Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein-Protein Interaction
    Chessari, Gianni
    Hardcastle, Ian R.
    Ahn, Jong Sook
    Anil, Burcu
    Anscombe, Elizabeth
    Bawn, Ruth H.
    Bevan, Luke D.
    Blackburn, Timothy J.
    Buck, Ildiko
    Cano, Celine
    Carbain, Benoit
    Castro, Juan
    Cons, Ben
    Cully, Sarah J.
    Endicott, Jane A.
    Fazal, Lynsey
    Golding, Bernard T.
    Griffin, Roger J.
    Haggerty, Karen
    Harnor, Suzannah J.
    Hearn, Keisha
    Hobson, Stephen
    Holvey, Rhian S.
    Howard, Steven
    Jennings, Claire E.
    Johnson, Christopher N.
    Lunec, John
    Miller, Duncan C.
    Newell, David R.
    Noble, Martin E. M.
    Reeks, Judith
    Revill, Charlotte H.
    Riedinger, Christiane
    St Denis, Jeffrey D.
    Tamanini, Emiliano
    Thomas, Huw
    Thompson, Neil T.
    Vinkovic, Mladen
    Wedge, Stephen R.
    Williams, Pamela A.
    Wilsher, Nicola E.
    Zhang, Bian
    Zhao, Yan
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (07) : 4071 - 4088
  • [44] Discovery of sulfonamide-piperidinones as potent inhibitors of the MDM2-p53 protein-protein interaction
    Li, Zhihong
    Fu, Jiasheng
    Rew, Yosup
    Gribble, Michael W.
    Canon, Jude
    Chen, Ada
    Eksterowicz, John
    Huang, Xin
    Jin, Lixia
    Lo, Mei-Chu
    McGee, Lawrence R.
    Osgood, Tao
    Saiki, Anne Y.
    Shaffer, Paul
    Sun, Daqing
    Wortman, Sarah
    Ye, Qiuping
    Yu, Dongyin
    Zhao, Xiaoning
    Zhou, Jing
    Oliner, Jonathan D.
    Olson, Steve H.
    Medina, Julio C.
    CANCER RESEARCH, 2015, 75
  • [45] Design and synthesis of non-peptidic a-helix mimics targeting for MDM2-p53 protein-protein interaction
    Zhou, Mingzhou
    Topper, Melissa E.
    Anderson, Laura
    McLaughlin, Jillian M.
    Santiago, Daniel N.
    Fronczek, Frank R.
    Guida, Wayne C.
    McLaughlin, Mark L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
  • [46] Targeting the MDM2-p53 protein-protein interaction with prenylchalcones: Synthesis of a small library and evaluation of potential antitumor activity
    Brandao, Pedro
    Loureiro, Joana B.
    Carvalho, Sylvie
    Hamadou, Meriem Hadjer
    Cravo, Sara
    Moreira, Joana
    Pereira, Daniela
    Palmeira, Andreia
    Pinto, Madalena
    Saraiva, Lucilia
    Cidade, Honorina
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 156 : 711 - 721
  • [47] DISRUPTION OF P53/MDM2/MDMX PROTEIN-PROTEIN INTERACTIONS
    Topper, M.
    Zhou, M.
    Anderson, L.
    McLaughlin, M.
    BIOPOLYMERS, 2009, 92 (04) : 332 - 332
  • [48] Design, synthesis, and biological evaluation of furan-bearing pyrazolo[3,4-b]pyridines as novel inhibitors of CDK2 and P53-MDM2 protein-protein interaction
    Ezzat, Manal Abdel Fattah
    Elmasry, Ghada F.
    Abd El-Mageed, Menna M. A.
    Fouad, Marwa A.
    Abdel-Aziz, Hatem A.
    Elewa, Safaa I.
    DRUG DEVELOPMENT RESEARCH, 2023, 84 (06) : 1183 - 1203
  • [49] New chemical tools for disrupting the MDM2/p53 protein-protein interaction: Identification, synthesis and biological evaluation of a novel class of MDM2/p53 inhibitors
    Pernazza, Daniele
    Li, Xiaolong
    Lawrence, Harshani R.
    Guida, Wayne C.
    DuBoulay, Courtney J.
    Watts, Shawn
    Sebti, Sayd M.
    Chen, Jiandong
    Lawrence, Nicholas J.
    CANCER RESEARCH, 2011, 71
  • [50] Inhibition of p53-MDM2 protein interaction reduces tumor growth in a mouse melanoma model.
    Ingelshed, Katrine
    Lianoudaki, Danai
    Lama, Dilraj
    Sohn, Silke
    Fritz, Nicolas
    Jiang, Long
    Wermeling, Fredrik
    Karlsson, Mikael
    Lane, David P.
    Sedimbi, Saikiran K.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 71 - 71